Hiperozmolar Hiperglisemik Durum (HHD)

Yazarlar

Adem Kaya

Özet

Hiperozmolar hiperglisemik durum (HHD), genellikle tanı konulmamış veya kontrolsüz tip 2 diyabetli yaşlı hastalarda gelişen, ilerleyici hiperglisemi ve hiperozmolarite ile karakterize, mortalitesi %5-20 arasında değişen acil bir metabolik tablodur. Enfeksiyonlar (pnömoni, idrar yolu enfeksiyonu), akut tıbbi durumlar, bazı ilaçlar ve kısıtlı sıvı alımı HHD'nin en yaygın tetikleyicileridir. Diyabetik ketoasidozdan farklı olarak insülinin mutlak değil rölatif eksikliği lipoliz ve ketogenezi baskıladığından ketonemi belirgin değildir. Ciddi hiperglisemi sonucu gelişen ozmotik diürez; vücutta 8-12 litrelik sıvı kaybına, şiddetli dehidratasyona, elektrolit bozukluklarına, doku hipoperfüzyonuna ve tromboemboli riskine yol açmaktadır. Klinik tabloda poliüri ve polidipsinin yanı sıra serum ozmolaritesiyle doğru orantılı olarak letarji, nöbet ve koma gibi nörolojik bozukluklar öne çıkar. HHD tanısı; serum glukozunun >600 mg/dL, plazma ozmolaritesinin >320 mOsm/kg, serum bikarbonatının >15 mEq/L, pH değerinin >7,30 olması ve minimal/negatif keton varlığı ile konur. Tedavinin temel hedefleri; hidrasyonun ve doku perfüzyonunun sağlanması, elektrolit anormalliklerinin düzeltilmesi ve hiperglisemi ile ozmolaritenin aşamalı olarak düşürülmesidir. Sıvı resüsitasyonunda öncelikle %0,9 NaCl kullanılır; potasyum düzeyi ≥3,3 mEq/L olunca iv insülin infüzyonuna başlanır. Ozmolaritenin hızlı düzeltilmesi serebral ödem gibi ölümcül komplikasyonlara yol açabileceğinden tedavi hızı dikkatle kontrol edilmeli ve hastalar yoğun bakımda takip edilmelidir.

 

Referanslar

Charles S. Graffeo. Hyperosmolar Hyperglycemic State. In: Tintinalli JE, Ma OJ, Yealy DM, Meckler GD, Stapczynski JS, Cline DM, Thomas SH, editors. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. Ninth Edition. New York: McGraw-Hill; 2020. p.1443-1447.

Kitabchi AE, Umpierrez GE, Murphy MB, et al. Management of Hyperglycemic Crises in Patients With Diabetes. Diabetes Care. 2001 Jan;24(1):131-53. doi: 10.2337/diacare.24.1.131.

Pasquel FJ, and Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care. 2014 Nov. 37 (11):3124-31. doi: 10.2337/dc14-0984

Kitabchi AE, Umpierrez GE, Murphy MB, et al. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006 Dec. 29(12):2739-48.

Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177. doi: 10.1111/pedi.12701.

Lu CL, Chang HH, Chen HF, et al. Inverse relationship between ambient temperature and admissions for diabetic ketoacidosis and hyperglycemic hyperosmolar state: A 14-year time-series analysis. Environ Int. 2016 Sep;94:642-648. doi: 10.1016/j.envint.2016.06.032.

Kreider KE, Gabrielski AA, and Hammonds FB. Hyperglycemia Syndromes. Nurs Clin N Am 53 (2018) 303–317. https://doi.org/10.1016/j.cnur.2018.04.001

Pasquel FJ, Tsegka K, Wang H, et al. Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study. http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc19-1168/-/DC1.

Gosmanov AR, Gosmanova EO, Kitabchi AE. Hyperglycemic Crises:

Diabetic Ketoacidosis (DKA), And Hyperglycemic Hyperosmolar State (HHS) [Updated 2018 May 17]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279052/

Adeyinka A, Kondamudi NP. Hyperosmolar Hyperglycemic Nonketotic Coma. [Updated 2020 May 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482142/

Umpierrez G, Freire AX. Abdominal pain in patients with hyperglycemic crises. J Crit Care. 2002 Mar;17(1):63-7. doi: 10.1053/jcrc.2002.33030.

Ahuja N, Palanichamy N, Mackin P, Lloyd A. Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature. J Psychopharmacol. 2010 Jan;24(1):125-30. doi: 10.1177/0269881108096901.

Campanella LM, Lartey R, Shih R. Severe hyperglycemic hyperosmolar nonketotic coma in a nondiabetic patient receiving aripiprazole. Ann Emerg Med. 2009 Feb;53(2):264-6. doi: 10.1016/j.annemergmed.2008.04.002.

Bradford AL, Crider CC, Xu X, Naqvi SH. Predictors of Recurrent Hospital Admission for Patients Presenting With Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. J Clin Med Res. 2017;9(1):35-39. doi: https://doi.org/10.14740/jocmr2792w

Agrawal S, Baird GL, Quintos JB, et al. Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes. Endocr Pract. 2018 Aug;24(8):726-732. doi: 10.4158/EP-2018-0120.

Kao Y, Hsu CC, Weng SF, et al. Subsequent mortality after hyperglycemic crisis episode in the non-elderly: a national population-based cohort study. Endocrine. 2016 Jan;51(1):72-82. doi: 10.1007/s12020-015-0669-8.

Issa M, Alqahtani F, Ziada KM, et al. Incidence and Outcomes of Non-ST Elevation Myocardial Infarction in Patients Hospitalized with Decompensated Diabetes. Am J Cardiol. 2018 Oct 15;122(8):1297-1302. doi: 10.1016/j.amjcard.2018.07.004.

Rosa EC, Lopes AC, Liberatori Filho AW, et al. Rhabdomyolysis due to hyperosmolarity leading to acute renal failure. Ren Fail. 1997 Mar;19(2):295301. doi: 10.3109/08860229709026292.

Slovis CM, Mork VG, Slovis RJ, Bain RP. Diabetic ketoacidosis and infection: leukocyte count and differential as early predictors of serious infection. Am J Emerg Med. 1987 Jan;5(1):1-5. doi: 10.1016/07356757(87)90280-4.

Schaapveld-Davis CM, Negrete AL, Hudson JQ, et al. End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State. Clin Diabetes. 2017 Oct;35(4):202-208. doi: 10.2337/cd16-0060.

Middleton P, Kelly AM, Brown J, at al. Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate. Emerg Med J. 2006 Aug;23(8):622-4. doi: 10.1136/emj.2006.035915.

Gershkovich B, English SW, Doyle M-A, et al. Choice of crystalloid fluid in the treatment of hyperglycemic emergencies: a systematic review protocol. Syst Rev. 2019 Eyl 3; 8 (1): 228. doi: 10.1186 / s13643-019-1130-5.

Echouffo-Tcheugui JB, & Garg R. Management of Hyperglycemia and Diabetes in the Emergency Department. Curr Diab Rep (2017) 17: 56. DOI: 10.1007/s11892-017-0883-2

Thomovsky E. Fluid and Electrolyte Therapy in Diabetic Ketoacidosis. Vet Clin North Am Small Anim Pract. 2017 Mar;47(2):491-503. doi: 10.1016/j.cvsm.2016.09.012.

Baldrighi M, Sainaghi PP, Bellan M, et al. Hyperglycemic Hyperosmolar State: A Pragmatic Approach to Properly Manage Sodium Derangements. Current Diabetes Reviews, 2018, 14, 534-541. DOI: 10.2174/1573399814666180320091451

Munoz C, Villanueva G, Fogg L, et al. Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI). J Emerg Med. 2011 May;40(5):493-8. doi: 10.1016/j.jemermed.2008.03.017.

Chua HR, Schneider A, & Bellomo R. Bicarbonate in diabetic ketoacidosis – a systematic review. Annals of Intensive Care 2011, 1:23. Available from: http://www.annalsofintensivecare.com/content/1/1/23

Cardoso L, Vicente N, Rodrigues D, et al. Controversies in the management of hyperglycaemic emergencies in adults with diabetes. Metabolism (2016), doi: 10.1016/j.metabol.2016.11.010

Sayfalar

33-64

Yayınlanan

1 Haziran 2021

Lisans

Lisans